Latest Lead News

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

Havilah Resources reports robust drilling, metallurgical, and mining study outcomes at its Mutooroo copper-cobalt-gold project, with JX Advanced Metals Corporation negotiating a pre-feasibility study agreement that could lead to equity investment.

Dicker Data reported a 2.9% increase in FY24 gross revenue to $3.37 billion with stable EBITDA, while FY25 starts strong with 17.4% sales growth driven by AI and Windows 10 refresh demand.

Koba Resources is set to raise $1.7 million to fund its next phase of drilling at the promising Yarramba Uranium Project, following a successful initial campaign that uncovered multiple high-grade uranium deposits.

Kelsian’s Tower Transit Singapore has won two-year extensions for its Bulim and Sembawang-Yishun bus service contracts, reinforcing its foothold in Singapore’s public transport sector.

Chilwa Minerals has reported impressive high-grade heavy mineral sand assay results from its Mpyupyu Dune deposit in Malawi, confirming thicker and richer mineralisation than previously estimated. These findings pave the way for an upcoming scoping study and resource upgrades.

Estrella Resources has entered a landmark Master Agreement with Indonesian firm PT Raka Energi Mandiri, granting exclusive rights to market and purchase limestone from Timor-Leste, targeting sales of up to 500 million tonnes over five years.

Nimy Resources has raised $2.75 million through a share placement to fast-track exploration and resource definition at its promising Block 3 gallium discovery in Western Australia amid soaring global gallium prices.

Microba Life Sciences reveals breakthrough data showing its MetaPanel™ test detects elusive gastrointestinal pathogens in 20% of chronic cases, enabling targeted treatment and complete symptom resolution.

Iltani Resources has raised $1.8 million through a share placement and launched a $1 million Share Purchase Plan to fund exploration at its promising Orient Silver-Indium Project.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

Oceana Lithium Limited has successfully raised $667,000 through a discounted share placement, attracting strong support from institutional and high-net-worth investors. The funds will accelerate exploration and development across its Australian and Brazilian lithium assets.